nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—Topoisomerase Inhibitors—Epirubicin—liver cancer	0.252	0.519	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Doxorubicin—liver cancer	0.233	0.481	CiPCiCtD
Mitoxantrone—sarcoma—liver cancer	0.214	1	CtDrD
Mitoxantrone—CYP2E1—liver cancer	0.0891	1	CbGaD
Mitoxantrone—TOP2A—Epirubicin—liver cancer	0.0401	0.276	CbGbCtD
Mitoxantrone—ABCC1—Epirubicin—liver cancer	0.0222	0.153	CbGbCtD
Mitoxantrone—TOP2A—Doxorubicin—liver cancer	0.0213	0.147	CbGbCtD
Mitoxantrone—CYP1B1—Doxorubicin—liver cancer	0.0166	0.115	CbGbCtD
Mitoxantrone—ABCG2—Sorafenib—liver cancer	0.013	0.0898	CbGbCtD
Mitoxantrone—ABCC1—Doxorubicin—liver cancer	0.0118	0.0814	CbGbCtD
Mitoxantrone—ABCG2—Doxorubicin—liver cancer	0.0079	0.0545	CbGbCtD
Mitoxantrone—ABCB1—Sorafenib—liver cancer	0.00469	0.0324	CbGbCtD
Mitoxantrone—ABCB1—Doxorubicin—liver cancer	0.00285	0.0197	CbGbCtD
Mitoxantrone—CYP3A4—Sorafenib—liver cancer	0.00281	0.0194	CbGbCtD
Mitoxantrone—CYP3A4—Doxorubicin—liver cancer	0.00171	0.0118	CbGbCtD
Mitoxantrone—Myocardial infarction—Sorafenib—liver cancer	0.000146	0.00399	CcSEcCtD
Mitoxantrone—Bone marrow depression—Epirubicin—liver cancer	0.000146	0.00398	CcSEcCtD
Mitoxantrone—Stomatitis—Sorafenib—liver cancer	0.000145	0.00397	CcSEcCtD
Mitoxantrone—Jaundice—Sorafenib—liver cancer	0.000145	0.00397	CcSEcCtD
Mitoxantrone—TOP2A—Doxorubicin—Epirubicin—liver cancer	0.000139	0.173	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Epirubicin—liver cancer	0.000139	0.173	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Epirubicin—liver cancer	0.000139	0.173	CbGdCrCtD
Mitoxantrone—Bone marrow depression—Doxorubicin—liver cancer	0.000135	0.00369	CcSEcCtD
Mitoxantrone—Haemoglobin—Sorafenib—liver cancer	0.000135	0.00367	CcSEcCtD
Mitoxantrone—Haemorrhage—Sorafenib—liver cancer	0.000134	0.00365	CcSEcCtD
Mitoxantrone—TOP2A—Epirubicin—Doxorubicin—liver cancer	0.000129	0.16	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Doxorubicin—liver cancer	0.000129	0.16	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Doxorubicin—liver cancer	0.000129	0.16	CbGdCrCtD
Mitoxantrone—Fungal infection—Epirubicin—liver cancer	0.000128	0.00348	CcSEcCtD
Mitoxantrone—Necrosis—Epirubicin—liver cancer	0.000126	0.00343	CcSEcCtD
Mitoxantrone—Petechiae—Epirubicin—liver cancer	0.00012	0.00327	CcSEcCtD
Mitoxantrone—Arrhythmia—Sorafenib—liver cancer	0.00012	0.00326	CcSEcCtD
Mitoxantrone—Alopecia—Sorafenib—liver cancer	0.000118	0.00323	CcSEcCtD
Mitoxantrone—Fungal infection—Doxorubicin—liver cancer	0.000118	0.00322	CcSEcCtD
Mitoxantrone—Erythema—Sorafenib—liver cancer	0.000117	0.00318	CcSEcCtD
Mitoxantrone—Necrosis—Doxorubicin—liver cancer	0.000116	0.00317	CcSEcCtD
Mitoxantrone—Dysgeusia—Sorafenib—liver cancer	0.000114	0.00312	CcSEcCtD
Mitoxantrone—Extravasation—Epirubicin—liver cancer	0.000113	0.00308	CcSEcCtD
Mitoxantrone—Amenorrhoea—Epirubicin—liver cancer	0.000112	0.00306	CcSEcCtD
Mitoxantrone—Petechiae—Doxorubicin—liver cancer	0.000111	0.00302	CcSEcCtD
Mitoxantrone—Viral infection—Epirubicin—liver cancer	0.000109	0.00298	CcSEcCtD
Mitoxantrone—Anaemia—Sorafenib—liver cancer	0.000108	0.00294	CcSEcCtD
Mitoxantrone—Hypocalcaemia—Epirubicin—liver cancer	0.000108	0.00294	CcSEcCtD
Mitoxantrone—Hyperuricaemia—Epirubicin—liver cancer	0.000106	0.0029	CcSEcCtD
Mitoxantrone—Extravasation—Doxorubicin—liver cancer	0.000104	0.00285	CcSEcCtD
Mitoxantrone—Leukopenia—Sorafenib—liver cancer	0.000104	0.00285	CcSEcCtD
Mitoxantrone—Blood bilirubin increased—Epirubicin—liver cancer	0.000104	0.00284	CcSEcCtD
Mitoxantrone—Ulcer—Epirubicin—liver cancer	0.000104	0.00284	CcSEcCtD
Mitoxantrone—Amenorrhoea—Doxorubicin—liver cancer	0.000104	0.00283	CcSEcCtD
Mitoxantrone—Bone pain—Epirubicin—liver cancer	0.000103	0.00281	CcSEcCtD
Mitoxantrone—Cough—Sorafenib—liver cancer	0.000102	0.00278	CcSEcCtD
Mitoxantrone—Viral infection—Doxorubicin—liver cancer	0.000101	0.00275	CcSEcCtD
Mitoxantrone—Hypertension—Sorafenib—liver cancer	0.000101	0.00275	CcSEcCtD
Mitoxantrone—Blood uric acid increased—Epirubicin—liver cancer	0.0001	0.00274	CcSEcCtD
Mitoxantrone—Hypocalcaemia—Doxorubicin—liver cancer	9.96e-05	0.00272	CcSEcCtD
Mitoxantrone—Arthralgia—Sorafenib—liver cancer	9.92e-05	0.00271	CcSEcCtD
Mitoxantrone—Myalgia—Sorafenib—liver cancer	9.92e-05	0.00271	CcSEcCtD
Mitoxantrone—Hyperuricaemia—Doxorubicin—liver cancer	9.83e-05	0.00268	CcSEcCtD
Mitoxantrone—Hyperkalaemia—Epirubicin—liver cancer	9.68e-05	0.00264	CcSEcCtD
Mitoxantrone—Blood bilirubin increased—Doxorubicin—liver cancer	9.64e-05	0.00263	CcSEcCtD
Mitoxantrone—Ulcer—Doxorubicin—liver cancer	9.64e-05	0.00263	CcSEcCtD
Mitoxantrone—Bone pain—Doxorubicin—liver cancer	9.52e-05	0.0026	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Sorafenib—liver cancer	9.51e-05	0.0026	CcSEcCtD
Mitoxantrone—Infection—Sorafenib—liver cancer	9.45e-05	0.00258	CcSEcCtD
Mitoxantrone—Shock—Sorafenib—liver cancer	9.36e-05	0.00255	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Sorafenib—liver cancer	9.31e-05	0.00254	CcSEcCtD
Mitoxantrone—Blood urea increased—Epirubicin—liver cancer	9.3e-05	0.00254	CcSEcCtD
Mitoxantrone—Blood uric acid increased—Doxorubicin—liver cancer	9.28e-05	0.00253	CcSEcCtD
Mitoxantrone—Skin disorder—Sorafenib—liver cancer	9.24e-05	0.00252	CcSEcCtD
Mitoxantrone—Anorexia—Sorafenib—liver cancer	9.07e-05	0.00247	CcSEcCtD
Mitoxantrone—Hyperkalaemia—Doxorubicin—liver cancer	8.96e-05	0.00244	CcSEcCtD
Mitoxantrone—Ecchymosis—Epirubicin—liver cancer	8.91e-05	0.00243	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Sorafenib—liver cancer	8.67e-05	0.00237	CcSEcCtD
Mitoxantrone—Blood urea increased—Doxorubicin—liver cancer	8.61e-05	0.00235	CcSEcCtD
Mitoxantrone—Sepsis—Epirubicin—liver cancer	8.55e-05	0.00233	CcSEcCtD
Mitoxantrone—Dyspnoea—Sorafenib—liver cancer	8.48e-05	0.00231	CcSEcCtD
Mitoxantrone—Dyspepsia—Sorafenib—liver cancer	8.37e-05	0.00229	CcSEcCtD
Mitoxantrone—Phlebitis—Epirubicin—liver cancer	8.3e-05	0.00227	CcSEcCtD
Mitoxantrone—Decreased appetite—Sorafenib—liver cancer	8.27e-05	0.00226	CcSEcCtD
Mitoxantrone—Ecchymosis—Doxorubicin—liver cancer	8.24e-05	0.00225	CcSEcCtD
Mitoxantrone—Fatigue—Sorafenib—liver cancer	8.2e-05	0.00224	CcSEcCtD
Mitoxantrone—Constipation—Sorafenib—liver cancer	8.13e-05	0.00222	CcSEcCtD
Mitoxantrone—Pain—Sorafenib—liver cancer	8.13e-05	0.00222	CcSEcCtD
Mitoxantrone—Sepsis—Doxorubicin—liver cancer	7.91e-05	0.00216	CcSEcCtD
Mitoxantrone—Cardiac failure congestive—Epirubicin—liver cancer	7.89e-05	0.00215	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Sorafenib—liver cancer	7.78e-05	0.00212	CcSEcCtD
Mitoxantrone—Renal failure acute—Epirubicin—liver cancer	7.75e-05	0.00211	CcSEcCtD
Mitoxantrone—Phlebitis—Doxorubicin—liver cancer	7.68e-05	0.0021	CcSEcCtD
Mitoxantrone—Urticaria—Sorafenib—liver cancer	7.56e-05	0.00206	CcSEcCtD
Mitoxantrone—Abdominal pain—Sorafenib—liver cancer	7.52e-05	0.00205	CcSEcCtD
Mitoxantrone—Body temperature increased—Sorafenib—liver cancer	7.52e-05	0.00205	CcSEcCtD
Mitoxantrone—Anaphylactoid reaction—Epirubicin—liver cancer	7.39e-05	0.00202	CcSEcCtD
Mitoxantrone—Cardiac failure—Epirubicin—liver cancer	7.33e-05	0.002	CcSEcCtD
Mitoxantrone—Cardiac failure congestive—Doxorubicin—liver cancer	7.3e-05	0.00199	CcSEcCtD
Mitoxantrone—Hyponatraemia—Epirubicin—liver cancer	7.18e-05	0.00196	CcSEcCtD
Mitoxantrone—Renal failure acute—Doxorubicin—liver cancer	7.17e-05	0.00196	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Epirubicin—liver cancer	7.15e-05	0.00195	CcSEcCtD
Mitoxantrone—Hypersensitivity—Sorafenib—liver cancer	7.01e-05	0.00191	CcSEcCtD
Mitoxantrone—Anaphylactoid reaction—Doxorubicin—liver cancer	6.84e-05	0.00187	CcSEcCtD
Mitoxantrone—Asthenia—Sorafenib—liver cancer	6.82e-05	0.00186	CcSEcCtD
Mitoxantrone—Cardiac failure—Doxorubicin—liver cancer	6.78e-05	0.00185	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Epirubicin—liver cancer	6.7e-05	0.00183	CcSEcCtD
Mitoxantrone—Dehydration—Epirubicin—liver cancer	6.65e-05	0.00182	CcSEcCtD
Mitoxantrone—Hyponatraemia—Doxorubicin—liver cancer	6.64e-05	0.00181	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	6.62e-05	0.00181	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Epirubicin—liver cancer	6.53e-05	0.00178	CcSEcCtD
Mitoxantrone—Hypokalaemia—Epirubicin—liver cancer	6.51e-05	0.00178	CcSEcCtD
Mitoxantrone—Diarrhoea—Sorafenib—liver cancer	6.51e-05	0.00178	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Epirubicin—liver cancer	6.44e-05	0.00176	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Epirubicin—liver cancer	6.31e-05	0.00172	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Doxorubicin—liver cancer	6.2e-05	0.00169	CcSEcCtD
Mitoxantrone—Dehydration—Doxorubicin—liver cancer	6.15e-05	0.00168	CcSEcCtD
Mitoxantrone—Vomiting—Sorafenib—liver cancer	6.05e-05	0.00165	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Doxorubicin—liver cancer	6.04e-05	0.00165	CcSEcCtD
Mitoxantrone—Hypokalaemia—Doxorubicin—liver cancer	6.02e-05	0.00164	CcSEcCtD
Mitoxantrone—Rash—Sorafenib—liver cancer	6e-05	0.00164	CcSEcCtD
Mitoxantrone—Dermatitis—Sorafenib—liver cancer	5.99e-05	0.00164	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Doxorubicin—liver cancer	5.96e-05	0.00163	CcSEcCtD
Mitoxantrone—Headache—Sorafenib—liver cancer	5.96e-05	0.00163	CcSEcCtD
Mitoxantrone—Pancytopenia—Epirubicin—liver cancer	5.87e-05	0.0016	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Doxorubicin—liver cancer	5.84e-05	0.00159	CcSEcCtD
Mitoxantrone—Neutropenia—Epirubicin—liver cancer	5.78e-05	0.00158	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Epirubicin—liver cancer	5.75e-05	0.00157	CcSEcCtD
Mitoxantrone—Nausea—Sorafenib—liver cancer	5.65e-05	0.00154	CcSEcCtD
Mitoxantrone—Weight increased—Epirubicin—liver cancer	5.63e-05	0.00154	CcSEcCtD
Mitoxantrone—Weight decreased—Epirubicin—liver cancer	5.59e-05	0.00153	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Epirubicin—liver cancer	5.58e-05	0.00152	CcSEcCtD
Mitoxantrone—Pneumonia—Epirubicin—liver cancer	5.54e-05	0.00151	CcSEcCtD
Mitoxantrone—Drowsiness—Epirubicin—liver cancer	5.51e-05	0.0015	CcSEcCtD
Mitoxantrone—Pancytopenia—Doxorubicin—liver cancer	5.43e-05	0.00148	CcSEcCtD
Mitoxantrone—Renal failure—Epirubicin—liver cancer	5.42e-05	0.00148	CcSEcCtD
Mitoxantrone—Stomatitis—Epirubicin—liver cancer	5.37e-05	0.00147	CcSEcCtD
Mitoxantrone—Jaundice—Epirubicin—liver cancer	5.37e-05	0.00147	CcSEcCtD
Mitoxantrone—Urinary tract infection—Epirubicin—liver cancer	5.36e-05	0.00146	CcSEcCtD
Mitoxantrone—Conjunctivitis—Epirubicin—liver cancer	5.36e-05	0.00146	CcSEcCtD
Mitoxantrone—Neutropenia—Doxorubicin—liver cancer	5.35e-05	0.00146	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Doxorubicin—liver cancer	5.32e-05	0.00145	CcSEcCtD
Mitoxantrone—Sweating—Epirubicin—liver cancer	5.28e-05	0.00144	CcSEcCtD
Mitoxantrone—Haematuria—Epirubicin—liver cancer	5.26e-05	0.00143	CcSEcCtD
Mitoxantrone—Weight increased—Doxorubicin—liver cancer	5.21e-05	0.00142	CcSEcCtD
Mitoxantrone—Weight decreased—Doxorubicin—liver cancer	5.17e-05	0.00141	CcSEcCtD
Mitoxantrone—Sinusitis—Epirubicin—liver cancer	5.17e-05	0.00141	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Doxorubicin—liver cancer	5.16e-05	0.00141	CcSEcCtD
Mitoxantrone—Agranulocytosis—Epirubicin—liver cancer	5.14e-05	0.0014	CcSEcCtD
Mitoxantrone—Pneumonia—Doxorubicin—liver cancer	5.13e-05	0.0014	CcSEcCtD
Mitoxantrone—Drowsiness—Doxorubicin—liver cancer	5.1e-05	0.00139	CcSEcCtD
Mitoxantrone—Bradycardia—Epirubicin—liver cancer	5.04e-05	0.00137	CcSEcCtD
Mitoxantrone—Renal failure—Doxorubicin—liver cancer	5.01e-05	0.00137	CcSEcCtD
Mitoxantrone—Haemoglobin—Epirubicin—liver cancer	4.97e-05	0.00136	CcSEcCtD
Mitoxantrone—Jaundice—Doxorubicin—liver cancer	4.97e-05	0.00136	CcSEcCtD
Mitoxantrone—Stomatitis—Doxorubicin—liver cancer	4.97e-05	0.00136	CcSEcCtD
Mitoxantrone—Rhinitis—Epirubicin—liver cancer	4.96e-05	0.00135	CcSEcCtD
Mitoxantrone—Conjunctivitis—Doxorubicin—liver cancer	4.96e-05	0.00135	CcSEcCtD
Mitoxantrone—Urinary tract infection—Doxorubicin—liver cancer	4.96e-05	0.00135	CcSEcCtD
Mitoxantrone—Hepatitis—Epirubicin—liver cancer	4.95e-05	0.00135	CcSEcCtD
Mitoxantrone—Haemorrhage—Epirubicin—liver cancer	4.95e-05	0.00135	CcSEcCtD
Mitoxantrone—Pharyngitis—Epirubicin—liver cancer	4.91e-05	0.00134	CcSEcCtD
Mitoxantrone—Sweating—Doxorubicin—liver cancer	4.89e-05	0.00133	CcSEcCtD
Mitoxantrone—Haematuria—Doxorubicin—liver cancer	4.86e-05	0.00133	CcSEcCtD
Mitoxantrone—Sinusitis—Doxorubicin—liver cancer	4.78e-05	0.00131	CcSEcCtD
Mitoxantrone—Agranulocytosis—Doxorubicin—liver cancer	4.76e-05	0.0013	CcSEcCtD
Mitoxantrone—Bradycardia—Doxorubicin—liver cancer	4.66e-05	0.00127	CcSEcCtD
Mitoxantrone—Haemoglobin—Doxorubicin—liver cancer	4.6e-05	0.00126	CcSEcCtD
Mitoxantrone—Rhinitis—Doxorubicin—liver cancer	4.59e-05	0.00125	CcSEcCtD
Mitoxantrone—Haemorrhage—Doxorubicin—liver cancer	4.58e-05	0.00125	CcSEcCtD
Mitoxantrone—Hepatitis—Doxorubicin—liver cancer	4.58e-05	0.00125	CcSEcCtD
Mitoxantrone—Pharyngitis—Doxorubicin—liver cancer	4.54e-05	0.00124	CcSEcCtD
Mitoxantrone—Chills—Epirubicin—liver cancer	4.44e-05	0.00121	CcSEcCtD
Mitoxantrone—Arrhythmia—Epirubicin—liver cancer	4.42e-05	0.00121	CcSEcCtD
Mitoxantrone—Alopecia—Epirubicin—liver cancer	4.37e-05	0.00119	CcSEcCtD
Mitoxantrone—Erythema—Epirubicin—liver cancer	4.31e-05	0.00118	CcSEcCtD
Mitoxantrone—Dysgeusia—Epirubicin—liver cancer	4.22e-05	0.00115	CcSEcCtD
Mitoxantrone—Back pain—Epirubicin—liver cancer	4.17e-05	0.00114	CcSEcCtD
Mitoxantrone—Chills—Doxorubicin—liver cancer	4.11e-05	0.00112	CcSEcCtD
Mitoxantrone—Arrhythmia—Doxorubicin—liver cancer	4.09e-05	0.00112	CcSEcCtD
Mitoxantrone—Vision blurred—Epirubicin—liver cancer	4.06e-05	0.00111	CcSEcCtD
Mitoxantrone—Alopecia—Doxorubicin—liver cancer	4.05e-05	0.0011	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Epirubicin—liver cancer	4e-05	0.00109	CcSEcCtD
Mitoxantrone—Erythema—Doxorubicin—liver cancer	3.99e-05	0.00109	CcSEcCtD
Mitoxantrone—Anaemia—Epirubicin—liver cancer	3.98e-05	0.00109	CcSEcCtD
Mitoxantrone—Dysgeusia—Doxorubicin—liver cancer	3.9e-05	0.00107	CcSEcCtD
Mitoxantrone—Malaise—Epirubicin—liver cancer	3.88e-05	0.00106	CcSEcCtD
Mitoxantrone—Leukopenia—Epirubicin—liver cancer	3.86e-05	0.00105	CcSEcCtD
Mitoxantrone—Back pain—Doxorubicin—liver cancer	3.86e-05	0.00105	CcSEcCtD
Mitoxantrone—Cough—Epirubicin—liver cancer	3.76e-05	0.00103	CcSEcCtD
Mitoxantrone—Vision blurred—Doxorubicin—liver cancer	3.76e-05	0.00103	CcSEcCtD
Mitoxantrone—Convulsion—Epirubicin—liver cancer	3.73e-05	0.00102	CcSEcCtD
Mitoxantrone—Hypertension—Epirubicin—liver cancer	3.72e-05	0.00102	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Doxorubicin—liver cancer	3.7e-05	0.00101	CcSEcCtD
Mitoxantrone—Anaemia—Doxorubicin—liver cancer	3.68e-05	0.00101	CcSEcCtD
Mitoxantrone—Chest pain—Epirubicin—liver cancer	3.67e-05	0.001	CcSEcCtD
Mitoxantrone—Myalgia—Epirubicin—liver cancer	3.67e-05	0.001	CcSEcCtD
Mitoxantrone—Arthralgia—Epirubicin—liver cancer	3.67e-05	0.001	CcSEcCtD
Mitoxantrone—Anxiety—Epirubicin—liver cancer	3.65e-05	0.000997	CcSEcCtD
Mitoxantrone—Discomfort—Epirubicin—liver cancer	3.62e-05	0.000989	CcSEcCtD
Mitoxantrone—Malaise—Doxorubicin—liver cancer	3.59e-05	0.000981	CcSEcCtD
Mitoxantrone—Leukopenia—Doxorubicin—liver cancer	3.57e-05	0.000974	CcSEcCtD
Mitoxantrone—Confusional state—Epirubicin—liver cancer	3.54e-05	0.000967	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Epirubicin—liver cancer	3.52e-05	0.000959	CcSEcCtD
Mitoxantrone—Oedema—Epirubicin—liver cancer	3.52e-05	0.000959	CcSEcCtD
Mitoxantrone—Infection—Epirubicin—liver cancer	3.49e-05	0.000953	CcSEcCtD
Mitoxantrone—Cough—Doxorubicin—liver cancer	3.48e-05	0.000949	CcSEcCtD
Mitoxantrone—Shock—Epirubicin—liver cancer	3.46e-05	0.000944	CcSEcCtD
Mitoxantrone—Convulsion—Doxorubicin—liver cancer	3.45e-05	0.000943	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Epirubicin—liver cancer	3.44e-05	0.000939	CcSEcCtD
Mitoxantrone—Hypertension—Doxorubicin—liver cancer	3.44e-05	0.000939	CcSEcCtD
Mitoxantrone—Tachycardia—Epirubicin—liver cancer	3.43e-05	0.000936	CcSEcCtD
Mitoxantrone—Skin disorder—Epirubicin—liver cancer	3.41e-05	0.000932	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Epirubicin—liver cancer	3.4e-05	0.000928	CcSEcCtD
Mitoxantrone—Arthralgia—Doxorubicin—liver cancer	3.39e-05	0.000926	CcSEcCtD
Mitoxantrone—Myalgia—Doxorubicin—liver cancer	3.39e-05	0.000926	CcSEcCtD
Mitoxantrone—Chest pain—Doxorubicin—liver cancer	3.39e-05	0.000926	CcSEcCtD
Mitoxantrone—Anxiety—Doxorubicin—liver cancer	3.38e-05	0.000923	CcSEcCtD
Mitoxantrone—Discomfort—Doxorubicin—liver cancer	3.35e-05	0.000915	CcSEcCtD
Mitoxantrone—Anorexia—Epirubicin—liver cancer	3.35e-05	0.000915	CcSEcCtD
Mitoxantrone—Hypotension—Epirubicin—liver cancer	3.28e-05	0.000897	CcSEcCtD
Mitoxantrone—Confusional state—Doxorubicin—liver cancer	3.28e-05	0.000895	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Doxorubicin—liver cancer	3.25e-05	0.000888	CcSEcCtD
Mitoxantrone—Oedema—Doxorubicin—liver cancer	3.25e-05	0.000888	CcSEcCtD
Mitoxantrone—Infection—Doxorubicin—liver cancer	3.23e-05	0.000882	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Epirubicin—liver cancer	3.2e-05	0.000874	CcSEcCtD
Mitoxantrone—Shock—Doxorubicin—liver cancer	3.2e-05	0.000873	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Doxorubicin—liver cancer	3.18e-05	0.000869	CcSEcCtD
Mitoxantrone—Tachycardia—Doxorubicin—liver cancer	3.17e-05	0.000866	CcSEcCtD
Mitoxantrone—Skin disorder—Doxorubicin—liver cancer	3.16e-05	0.000862	CcSEcCtD
Mitoxantrone—Paraesthesia—Epirubicin—liver cancer	3.16e-05	0.000862	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Doxorubicin—liver cancer	3.14e-05	0.000858	CcSEcCtD
Mitoxantrone—Dyspnoea—Epirubicin—liver cancer	3.13e-05	0.000855	CcSEcCtD
Mitoxantrone—Somnolence—Epirubicin—liver cancer	3.13e-05	0.000853	CcSEcCtD
Mitoxantrone—Anorexia—Doxorubicin—liver cancer	3.1e-05	0.000846	CcSEcCtD
Mitoxantrone—Dyspepsia—Epirubicin—liver cancer	3.09e-05	0.000845	CcSEcCtD
Mitoxantrone—Decreased appetite—Epirubicin—liver cancer	3.06e-05	0.000834	CcSEcCtD
Mitoxantrone—Hypotension—Doxorubicin—liver cancer	3.04e-05	0.00083	CcSEcCtD
Mitoxantrone—Fatigue—Epirubicin—liver cancer	3.03e-05	0.000827	CcSEcCtD
Mitoxantrone—Pain—Epirubicin—liver cancer	3.01e-05	0.000821	CcSEcCtD
Mitoxantrone—Constipation—Epirubicin—liver cancer	3.01e-05	0.000821	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Doxorubicin—liver cancer	2.96e-05	0.000809	CcSEcCtD
Mitoxantrone—Paraesthesia—Doxorubicin—liver cancer	2.92e-05	0.000797	CcSEcCtD
Mitoxantrone—Dyspnoea—Doxorubicin—liver cancer	2.9e-05	0.000792	CcSEcCtD
Mitoxantrone—Feeling abnormal—Epirubicin—liver cancer	2.9e-05	0.000791	CcSEcCtD
Mitoxantrone—Somnolence—Doxorubicin—liver cancer	2.89e-05	0.000789	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Epirubicin—liver cancer	2.87e-05	0.000785	CcSEcCtD
Mitoxantrone—Dyspepsia—Doxorubicin—liver cancer	2.86e-05	0.000781	CcSEcCtD
Mitoxantrone—Decreased appetite—Doxorubicin—liver cancer	2.83e-05	0.000772	CcSEcCtD
Mitoxantrone—Fatigue—Doxorubicin—liver cancer	2.8e-05	0.000765	CcSEcCtD
Mitoxantrone—Urticaria—Epirubicin—liver cancer	2.79e-05	0.000762	CcSEcCtD
Mitoxantrone—Constipation—Doxorubicin—liver cancer	2.78e-05	0.000759	CcSEcCtD
Mitoxantrone—Pain—Doxorubicin—liver cancer	2.78e-05	0.000759	CcSEcCtD
Mitoxantrone—Body temperature increased—Epirubicin—liver cancer	2.78e-05	0.000758	CcSEcCtD
Mitoxantrone—Abdominal pain—Epirubicin—liver cancer	2.78e-05	0.000758	CcSEcCtD
Mitoxantrone—Feeling abnormal—Doxorubicin—liver cancer	2.68e-05	0.000732	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Doxorubicin—liver cancer	2.66e-05	0.000726	CcSEcCtD
Mitoxantrone—Hypersensitivity—Epirubicin—liver cancer	2.59e-05	0.000707	CcSEcCtD
Mitoxantrone—Urticaria—Doxorubicin—liver cancer	2.58e-05	0.000705	CcSEcCtD
Mitoxantrone—Abdominal pain—Doxorubicin—liver cancer	2.57e-05	0.000702	CcSEcCtD
Mitoxantrone—Body temperature increased—Doxorubicin—liver cancer	2.57e-05	0.000702	CcSEcCtD
Mitoxantrone—Asthenia—Epirubicin—liver cancer	2.52e-05	0.000688	CcSEcCtD
Mitoxantrone—Diarrhoea—Epirubicin—liver cancer	2.41e-05	0.000656	CcSEcCtD
Mitoxantrone—Hypersensitivity—Doxorubicin—liver cancer	2.4e-05	0.000654	CcSEcCtD
Mitoxantrone—Asthenia—Doxorubicin—liver cancer	2.33e-05	0.000637	CcSEcCtD
Mitoxantrone—Vomiting—Epirubicin—liver cancer	2.24e-05	0.00061	CcSEcCtD
Mitoxantrone—Diarrhoea—Doxorubicin—liver cancer	2.23e-05	0.000607	CcSEcCtD
Mitoxantrone—Rash—Epirubicin—liver cancer	2.22e-05	0.000605	CcSEcCtD
Mitoxantrone—Dermatitis—Epirubicin—liver cancer	2.21e-05	0.000604	CcSEcCtD
Mitoxantrone—Headache—Epirubicin—liver cancer	2.2e-05	0.000601	CcSEcCtD
Mitoxantrone—Nausea—Epirubicin—liver cancer	2.09e-05	0.00057	CcSEcCtD
Mitoxantrone—Vomiting—Doxorubicin—liver cancer	2.07e-05	0.000564	CcSEcCtD
Mitoxantrone—Rash—Doxorubicin—liver cancer	2.05e-05	0.00056	CcSEcCtD
Mitoxantrone—Dermatitis—Doxorubicin—liver cancer	2.05e-05	0.000559	CcSEcCtD
Mitoxantrone—Headache—Doxorubicin—liver cancer	2.04e-05	0.000556	CcSEcCtD
Mitoxantrone—Nausea—Doxorubicin—liver cancer	1.93e-05	0.000527	CcSEcCtD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	5.63e-06	0.000192	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.62e-06	0.000191	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GOT2—liver cancer	5.57e-06	0.00019	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—RAF1—liver cancer	5.56e-06	0.000189	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.54e-06	0.000189	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN1A—liver cancer	5.51e-06	0.000187	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PIK3CA—liver cancer	5.46e-06	0.000186	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MTOR—liver cancer	5.43e-06	0.000185	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CB—liver cancer	5.43e-06	0.000185	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CRABP1—liver cancer	5.41e-06	0.000184	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—PPARA—liver cancer	5.41e-06	0.000184	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.4e-06	0.000184	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HPGDS—liver cancer	5.38e-06	0.000183	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.36e-06	0.000182	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.35e-06	0.000182	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.32e-06	0.000181	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CPT1B—liver cancer	5.27e-06	0.00018	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GLUL—liver cancer	5.27e-06	0.00018	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—HRAS—liver cancer	5.26e-06	0.000179	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HPGDS—liver cancer	5.2e-06	0.000177	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.17e-06	0.000176	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MYC—liver cancer	5.11e-06	0.000174	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDKN1B—liver cancer	5.1e-06	0.000174	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NR1H4—liver cancer	5.08e-06	0.000173	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HRAS—liver cancer	5.05e-06	0.000172	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6—liver cancer	5.03e-06	0.000171	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTA3—liver cancer	5e-06	0.00017	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2—liver cancer	4.99e-06	0.00017	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	4.95e-06	0.000169	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.87e-06	0.000166	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—JUN—liver cancer	4.85e-06	0.000165	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CTNNB1—liver cancer	4.82e-06	0.000164	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.81e-06	0.000164	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GOT1—liver cancer	4.81e-06	0.000164	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PSMA4—liver cancer	4.79e-06	0.000163	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PSMD10—liver cancer	4.79e-06	0.000163	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HPGDS—liver cancer	4.73e-06	0.000161	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.71e-06	0.00016	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDKN1A—liver cancer	4.7e-06	0.00016	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GOT2—liver cancer	4.66e-06	0.000159	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.65e-06	0.000158	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—AKT1—liver cancer	4.64e-06	0.000158	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PSMA4—liver cancer	4.64e-06	0.000158	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PSMD10—liver cancer	4.64e-06	0.000158	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK8—liver cancer	4.59e-06	0.000156	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTA4—liver cancer	4.57e-06	0.000156	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ALB—liver cancer	4.57e-06	0.000156	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—liver cancer	4.56e-06	0.000155	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	4.54e-06	0.000155	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GOT2—liver cancer	4.51e-06	0.000154	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—AKT1—liver cancer	4.46e-06	0.000152	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTA2—liver cancer	4.45e-06	0.000152	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	4.45e-06	0.000151	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PRKCE—liver cancer	4.43e-06	0.000151	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP2E1—liver cancer	4.38e-06	0.000149	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	4.33e-06	0.000147	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	4.32e-06	0.000147	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTA1—liver cancer	4.3e-06	0.000146	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	4.29e-06	0.000146	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NAT2—liver cancer	4.25e-06	0.000145	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.24e-06	0.000145	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP2E1—liver cancer	4.24e-06	0.000144	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PSMA4—liver cancer	4.22e-06	0.000144	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PSMD10—liver cancer	4.22e-06	0.000144	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—STAT3—liver cancer	4.2e-06	0.000143	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	4.19e-06	0.000143	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	4.17e-06	0.000142	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—RAF1—liver cancer	4.13e-06	0.000141	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.11e-06	0.00014	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GOT2—liver cancer	4.1e-06	0.00014	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYCS—liver cancer	4.1e-06	0.00014	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	4.09e-06	0.000139	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALDOB—liver cancer	4.07e-06	0.000139	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—UGDH—liver cancer	4.04e-06	0.000137	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GGT1—liver cancer	4.02e-06	0.000137	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GOT1—liver cancer	4.02e-06	0.000137	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	4.02e-06	0.000137	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CPT1B—liver cancer	3.97e-06	0.000135	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GLUL—liver cancer	3.97e-06	0.000135	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYCS—liver cancer	3.97e-06	0.000135	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GOT1—liver cancer	3.89e-06	0.000133	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GGT1—liver cancer	3.89e-06	0.000133	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CRABP1—liver cancer	3.89e-06	0.000132	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—H2AFX—liver cancer	3.87e-06	0.000132	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP2E1—liver cancer	3.86e-06	0.000131	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NR1H4—liver cancer	3.83e-06	0.00013	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—EPT1—liver cancer	3.8e-06	0.000129	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.77e-06	0.000129	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTA3—liver cancer	3.76e-06	0.000128	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—liver cancer	3.75e-06	0.000128	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	3.64e-06	0.000124	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.62e-06	0.000123	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTP1—liver cancer	3.62e-06	0.000123	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYCS—liver cancer	3.61e-06	0.000123	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KRAS—liver cancer	3.6e-06	0.000123	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TAT—liver cancer	3.6e-06	0.000123	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HMOX1—liver cancer	3.57e-06	0.000121	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GGT1—liver cancer	3.54e-06	0.000121	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GOT1—liver cancer	3.54e-06	0.000121	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTHFR—liver cancer	3.51e-06	0.000119	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTP1—liver cancer	3.5e-06	0.000119	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TERT—liver cancer	3.5e-06	0.000119	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.47e-06	0.000118	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.46e-06	0.000118	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HMOX1—liver cancer	3.45e-06	0.000117	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTA4—liver cancer	3.44e-06	0.000117	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HPGDS—liver cancer	3.4e-06	0.000116	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTA2—liver cancer	3.35e-06	0.000114	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTM1—liver cancer	3.32e-06	0.000113	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CA—liver cancer	3.31e-06	0.000113	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTA1—liver cancer	3.24e-06	0.00011	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.23e-06	0.00011	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTM1—liver cancer	3.21e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.21e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NAT2—liver cancer	3.2e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTP1—liver cancer	3.18e-06	0.000108	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP1A1—liver cancer	3.15e-06	0.000107	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HMOX1—liver cancer	3.14e-06	0.000107	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALDOB—liver cancer	3.07e-06	0.000104	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—liver cancer	3.06e-06	0.000104	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP1A1—liver cancer	3.05e-06	0.000104	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PSMD10—liver cancer	3.03e-06	0.000103	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PSMA4—liver cancer	3.03e-06	0.000103	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.95e-06	0.0001	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APC—liver cancer	2.95e-06	0.0001	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GOT2—liver cancer	2.95e-06	0.0001	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—liver cancer	2.94e-06	0.0001	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—liver cancer	2.93e-06	9.99e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CRABP1—liver cancer	2.93e-06	9.97e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.93e-06	9.96e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTM1—liver cancer	2.92e-06	9.95e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARA—liver cancer	2.88e-06	9.81e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.85e-06	9.71e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—liver cancer	2.84e-06	9.67e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARA—liver cancer	2.79e-06	9.49e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1A1—liver cancer	2.77e-06	9.44e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—BRAF—liver cancer	2.77e-06	9.43e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—liver cancer	2.71e-06	9.21e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYCS—liver cancer	2.59e-06	8.82e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CD—liver cancer	2.59e-06	8.82e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.59e-06	8.81e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—liver cancer	2.58e-06	8.8e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SERPINE1—liver cancer	2.56e-06	8.72e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HPGDS—liver cancer	2.56e-06	8.71e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GOT1—liver cancer	2.54e-06	8.66e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GGT1—liver cancer	2.54e-06	8.66e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARA—liver cancer	2.53e-06	8.63e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.5e-06	8.52e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CG—liver cancer	2.47e-06	8.4e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CPT1B—liver cancer	2.45e-06	8.33e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GLUL—liver cancer	2.45e-06	8.33e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.41e-06	8.2e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CG—liver cancer	2.39e-06	8.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARG—liver cancer	2.38e-06	8.11e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NR1H4—liver cancer	2.36e-06	8.03e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA3—liver cancer	2.32e-06	7.9e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RAF1—liver cancer	2.31e-06	7.87e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARG—liver cancer	2.3e-06	7.84e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTP1—liver cancer	2.28e-06	7.78e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PSMA4—liver cancer	2.28e-06	7.76e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PSMD10—liver cancer	2.28e-06	7.76e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CB—liver cancer	2.26e-06	7.69e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTOR—liver cancer	2.26e-06	7.69e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMOX1—liver cancer	2.25e-06	7.67e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GOT2—liver cancer	2.22e-06	7.55e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.17e-06	7.4e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CG—liver cancer	2.17e-06	7.39e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CD—liver cancer	2.17e-06	7.38e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—liver cancer	2.14e-06	7.29e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA4—liver cancer	2.12e-06	7.22e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1B—liver cancer	2.12e-06	7.21e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTM1—liver cancer	2.1e-06	7.15e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CD—liver cancer	2.1e-06	7.14e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARG—liver cancer	2.09e-06	7.13e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2E1—liver cancer	2.09e-06	7.1e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—liver cancer	2.07e-06	7.05e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA2—liver cancer	2.07e-06	7.04e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CTNNB1—liver cancer	2e-06	6.81e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA1—liver cancer	1.99e-06	6.79e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1A1—liver cancer	1.99e-06	6.78e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NAT2—liver cancer	1.97e-06	6.71e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.97e-06	6.7e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1A—liver cancer	1.95e-06	6.66e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYCS—liver cancer	1.95e-06	6.64e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GGT1—liver cancer	1.91e-06	6.52e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GOT1—liver cancer	1.91e-06	6.52e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CD—liver cancer	1.91e-06	6.5e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDOB—liver cancer	1.89e-06	6.44e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CB—liver cancer	1.89e-06	6.44e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—liver cancer	1.88e-06	6.41e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—liver cancer	1.85e-06	6.32e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CB—liver cancer	1.83e-06	6.23e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARA—liver cancer	1.82e-06	6.2e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CRABP1—liver cancer	1.8e-06	6.14e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—liver cancer	1.74e-06	5.94e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTP1—liver cancer	1.72e-06	5.86e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMOX1—liver cancer	1.7e-06	5.78e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CB—liver cancer	1.66e-06	5.66e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—liver cancer	1.62e-06	5.52e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—liver cancer	1.62e-06	5.51e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTM1—liver cancer	1.58e-06	5.38e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HPGDS—liver cancer	1.58e-06	5.37e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CG—liver cancer	1.56e-06	5.31e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARG—liver cancer	1.5e-06	5.12e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1A1—liver cancer	1.5e-06	5.1e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—liver cancer	1.5e-06	5.1e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PSMA4—liver cancer	1.4e-06	4.78e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PSMD10—liver cancer	1.4e-06	4.78e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—liver cancer	1.4e-06	4.76e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—liver cancer	1.38e-06	4.69e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARA—liver cancer	1.37e-06	4.67e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CD—liver cancer	1.37e-06	4.67e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GOT2—liver cancer	1.37e-06	4.65e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—liver cancer	1.35e-06	4.61e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2E1—liver cancer	1.28e-06	4.38e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—liver cancer	1.27e-06	4.33e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—liver cancer	1.22e-06	4.15e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYCS—liver cancer	1.2e-06	4.09e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CB—liver cancer	1.19e-06	4.07e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GGT1—liver cancer	1.18e-06	4.02e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GOT1—liver cancer	1.18e-06	4.02e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CG—liver cancer	1.17e-06	4e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—liver cancer	1.15e-06	3.92e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARG—liver cancer	1.13e-06	3.86e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—liver cancer	1.12e-06	3.83e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—liver cancer	1.11e-06	3.8e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTP1—liver cancer	1.06e-06	3.61e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMOX1—liver cancer	1.05e-06	3.56e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CD—liver cancer	1.03e-06	3.51e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—liver cancer	1.02e-06	3.47e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—liver cancer	1.01e-06	3.45e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTM1—liver cancer	9.74e-07	3.32e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—liver cancer	9.41e-07	3.21e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1A1—liver cancer	9.23e-07	3.14e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—liver cancer	9.1e-07	3.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CB—liver cancer	8.99e-07	3.06e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—liver cancer	8.61e-07	2.93e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARA—liver cancer	8.44e-07	2.88e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—liver cancer	8.28e-07	2.82e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—liver cancer	7.28e-07	2.48e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CG—liver cancer	7.23e-07	2.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARG—liver cancer	6.98e-07	2.38e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CD—liver cancer	6.36e-07	2.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—liver cancer	6.27e-07	2.14e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—liver cancer	5.95e-07	2.03e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CB—liver cancer	5.54e-07	1.89e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—liver cancer	5.48e-07	1.87e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—liver cancer	4.48e-07	1.52e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—liver cancer	3.38e-07	1.15e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—liver cancer	2.76e-07	9.4e-06	CbGpPWpGaD
